Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2
Part of paid clinical trials in Guilford, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07602218
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Clinical Decision Support
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Refined EMBED CDS — OTHERRefined EMBED CDS
- Provider alert to order consultation with addiction counselor — OTHERProvider alert to order consult with addiction counselor
Study Details
This study is stage 2, round 2 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Key Dates
- Start date
- May 21, 2026
- Status verified
- May 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Active Comparator: Refined EMBED CDSEMBED CDS refined based on previous results
- Experimental: Refined EMBED plus provider alert in Epic to order a consult with an addiction counselorProvider alert in Epic to order a consult with an addiction counselor to assess for eligibility and initiation of MOUD
Primary Outcome Measure
Proportion of encounters with an order for an addiction counselor consult [ Time Frame: Trial round start to end up to 3 months ]
Central Contacts
- Edward Melnick, MD, MHS203-785-4363
- Laurel Buchanan, MA203-785-4363
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale New Haven Shoreline Medical Center | Guilford | Connecticut | 06437 | - |
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | - |
| Yale New Haven Hospital- St. Raphael | New Haven | Connecticut | 06510 | - |
Find similar trials in Guilford, CT
Related Studies
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Cannabidiol in Opioid Use Disorder and Chronic PainEARLY_PHASE1 · Recruiting · Yale University · West Haven, Connecticut
- Neuroplasticity in Maternal Opioid Use Disorder (OUD)Recruiting · Yale University · New Haven, Connecticut
- Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved WomenPHASE4 · Recruiting · Yale University · Birmingham, Alabama